Brooklyn Investment Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$700K Sell
10,833
-1,410
-12% -$99.4K 0.02% 784
2025
Q4
$844K Buy
+12,243
New +$824K 0.04% 406
2025
Q3
– Sell
-2,595
Closed -$135K – 1522
2025
Q2
$135K Buy
2,595
+1,882
+264% +$107K 0.02% 782
2025
Q1
$45.5K Buy
713
+670
+1,558% +$38.9K 0.01% 823
2024
Q4
$2.06K Buy
+43
New +$2.21K ﹤0.01% 1454

Other funds holding HALO

Brooklyn Investment Group's HALO Position: Q1 2026 in Review

Brooklyn Investment Group reduced its Halozyme (HALO) stake by 12% in Q1 2026, selling an estimated $99.4K and leaving 10,833 shares worth $700K. The position accounts for 0.02% of the portfolio, ranked #784.

Brooklyn Investment Group first reported a position in HALO in Q4 2024 and has held it in 5 quarters since. The position peaked at $844K in Q4 2025. 637 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Brooklyn Investment Group held 10,833 shares of Halozyme worth $700K as of Q1 2026.
  • Brooklyn Investment Group sold 1,410 Halozyme shares in Q1 2026, an estimated $99.4K.
  • Halozyme made up 0.02% of Brooklyn Investment Group's portfolio in Q1 2026, its #784 holding.
  • Brooklyn Investment Group first reported a position in Halozyme in Q4 2024 and has held it in 5 quarters since.
  • Brooklyn Investment Group's Halozyme position peaked at $844K in Q4 2025.
  • 637 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.